Curis, Inc. To Present At Biotechnology Industry Organization (BIO) Investor Forum 2006

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, today announced that the company will be presenting at BIO Investor Forum 2006, which is being held from October 17 through October 19. The company’s presentation will take place on Wednesday, October 18th, in the Sea Cliff Room at the Palace Hotel in San Francisco.